Corporate Affairs, Communication and Policy Advocacy

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity:

The Senior Director, Corporate Affairs will lead the development and execution of oncology-focused Corporate Affairs strategies in the CNE that support the company’s mission of revolutionizing treatment for patients with RAS-addicted cancers.  These Corporate Affairs strategies bring together media relations, corporate public affairs, product communications, corporate reputation management and internal communications. 

This is an intentionally broad remit, spanning a wide range of disciplines. We are realistic that priorities will need to be set and will evolve over time. We are seeking a versatile leader who approaches this breadth as an opportunity and who understands that the scope of the role reflects the scale of our ambition as a growing business. 

Reporting to the VP, Corporate Affairs, Europe with a strong dotted line to the General Manager, CNE, this role ensures that the Corporate Affairs strategy is primarily supporting local priorities and market requirements.  The strategy should also be aligned with regional and global Corporate Affairs strategies. 

Key Responsibilities:

Media Relations

• Acts as CNE spokesperson, directing enquiries to internal experts as needed.

• Drives proactive media content and strategy around trial results, regulatory milestones, and major oncology congresses (ASCO, ESMO).

• Builds and maintains trusted relationships with top-tier CNE and trade media, ensuring accurate representation of company positions and achievements.

• Monitors media coverage and sentiment, flagging emerging narratives before they require a crisis response.

• Ensures consistent messaging across earned, owned, and shared channels, and aligns spokesperson strategy and media plans with global priorities.

Corporate Reputation Management and Corporate Public Affairs

• Owns the country-level corporate reputation strategy for [COUNTRY], ensuring consistency with the global corporate narrative and brand.